Authors:
Nilsson, T
Zetterberg, H
Wang, YC
Rymo, L
Citation: T. Nilsson et al., Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoidcell lines, J VIROLOGY, 75(13), 2001, pp. 5796-5811
Citation: V. Stemme et al., Quantitative analysis of specific mRNA species in minute cell samples by RT-PCR and flow cytometry, J IMMUNOL M, 249(1-2), 2001, pp. 223-233
Citation: M. Dufva et al., Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway, J GEN VIROL, 82, 2001, pp. 1581-1587
Authors:
Blennow, K
Ricksten, A
Prince, JA
Brookes, AJ
Emahazion, T
Wasslavik, C
Bogdanovic, N
Andreasen, N
Batsman, S
Marcusson, J
Nagga, K
Wallin, A
Regland, B
Olofsson, H
Hesse, C
Davidson, P
Minthon, L
Jansson, A
Palmqvist, L
Rymo, L
Citation: K. Blennow et al., No association between the alpha 2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression, J NEURAL TR, 107(8-9), 2000, pp. 1065-1079
Authors:
Sjoblom-Hallen, A
Yang, WW
Jansson, A
Rymo, L
Citation: A. Sjoblom-hallen et al., Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure, J VIROLOGY, 73(4), 1999, pp. 2983-2993
Authors:
Zetterberg, H
Stenglein, M
Jansson, A
Ricksten, A
Rymo, L
Citation: H. Zetterberg et al., Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stagesof infection, J GEN VIROL, 80, 1999, pp. 457-466